Dr. Reddy's Pharmaceutical Company to release Q2 FY08 results on October 24, 2007

Nov. 15, 2007 - PRLog -- Dr. Reddy's Laboratories  will announce results for the second quarter ended September 30, 2007 on Wednesday, October 24, 2007 after the Board Meeting. The results will be available on the Company’s website http://www.drreddys.com

Earnings Call:
Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.

Participants from India:
022.2781.3043
Stand by – 022.67763743

Participants from US:
US  -  TOLL FREE: 877 209 0463
US/International Toll Number : +1 706 643 0243
Conference ID: 19865215#

Singapore Toll Free Number: 800 101 1350

Audio Webcast:
The audio webcast of the earnings call will be available to all interested parties at http://www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through October 31, 2007.

Transcript:
The transcript of the earnings call will also be available on the Company's website.

About Dr Reddy’s:
Established in 1984, Dr. Reddy's  is a vertically integrated, global pharmaceutical company with proven research capabilities and presence across the pharmaceutical value chain. The company manufactures Active Pharmaceutical Ingredients and Finished Dosage forms and markets them globally, with a focus on United States, Europe, India and Russia. In addition, the drug discovery arm of the company conducts basic research in the areas of diabetes, cardiovascular, inflammation and bacterial infection. Website: http://www.drreddys.com

Contact
For further information please contact:
Investor Relations: Nikhil Shah (nikhilshah@drreddys.com) or on +91-40-66511532

# # #

About Dr. Reddy's Laboratories  is an emerging global pharmaceutical company established in 1984, with proven research capabilities. The Company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia. The Company conducts research in the areas of diabetes, cardiovascular and cancer.

Website: www.drreddys.com/